Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Sulindac | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | | Sulindac | hsa00220 | Arginine biosynthesis | 2.33E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Sulindac | hsa00310 | Lysine degradation | 6.96E-03 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Sulindac | hsa00480 | Glutathione metabolism | 3.29E-04 | 4 | Q9UJ14, Q16772, P09211, P30041 | GGTL3, GSTA3, GSTP1, PRDX6 | More | | Sulindac | hsa00500 | Starch and sucrose metabolism | 3.06E-05 | 4 | O43451, P46976, P35573, P06737 | MGAM, GYG1, AGL, PYGL | More | | Sulindac | hsa00515 | Mannose type O-glycan biosynthesis | 4.96E-02 | 1 | O75072 | FCMD | More | | Sulindac | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 2.03E-02 | 1 | P35557 | GCK | More | | Sulindac | hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate | 1.91E-02 | 1 | Q9NY97 | B3GNT2 | More | | Sulindac | hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 3.78E-02 | 1 | Q9NY97 | B3GNT2 | More | | Sulindac | hsa00620 | Pyruvate metabolism | 1.39E-03 | 4 | P40925, P40926, P51648, P14550 | MDH1, MDH2, ALDH3A2, AKR1A1 | More | | Sulindac | hsa00630 | Glyoxylate and dicarboxylate metabolism | 2.40E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Sulindac | hsa00730 | Thiamine metabolism | 1.38E-05 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | | Sulindac | hsa00740 | Riboflavin metabolism | 4.03E-02 | 1 | P24666 | ACP1 | More | | Sulindac | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Sulindac | hsa00982 | Drug metabolism - cytochrome P450 | 1.06E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Sulindac | hsa00983 | Drug metabolism - other enzymes | 1.72E-02 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Sulindac | hsa01100 | Metabolic pathways | 3.55E-03 | 34 | Q9NR34, P35790, P05089, Q16772, P09211, Q9UJ14, P30041, P32320, P22748, P40926, P55809, P06280, Q16875, O43286, O43451, Q7KZN9, P05186, P24666, P15121, Q9HCC0, P33121, Q9UHK6, Q86VZ5, P57054, Q9UNP4, Q9BX95, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737, Q9BQB6 | MAN1C1, CHKA, ARG1, GSTA3, GSTP1, GGTL3, PRDX6, CDA, CA4, MDH2, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, COX15, ALPL, ACP1, AKR1B1, MCCC2, ACSL1, AMACR, SGMS1, PIGP, ST3GAL5, SGPP1, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL, VKORC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P35790 | CHKA | Choline kinase alpha | -0.717 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q16772 | GSTA3 | Glutathione S-transferase A3 | -0.793 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P09211 | GSTP1 | Glutathione S-transferase P | 0.712 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9UJ14 | GGTL3 | Glutathione hydrolase 7 | 0.748 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P30041 | PRDX6 | Peroxiredoxin-6 | 0.75 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | 0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q7KZN9 | COX15 | Cytochrome c oxidase assembly protein COX15 homolog | 0.764 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.704 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.736 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | Q9BQB6 | VKORC1 | Vitamin K epoxide reductase complex subunit 1 | 0.731 |
| Sulindac | hsa01210 | 2-Oxocarboxylic acid metabolism | 1.91E-02 | 1 | P50213 | IDH3A | More | | Sulindac | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Sulindac | hsa01524 | Platinum drug resistance | 8.70E-04 | 7 | P10415, Q13489, Q16772, P09211, P78417, P23025, P43246 | BCL2, BIRC3, GSTA3, GSTP1, GSTO1, XPA, MSH2 | More | | Sulindac | hsa03008 | Ribosome biogenesis in eukaryotes | 2.52E-02 | 3 | P78345, O15381, Q9GZY0 | RPP38, NVL, NXF2; NXF2B | More | | Sulindac | hsa03010 | Ribosome | 1.88E-02 | 6 | P62753, P25398, P32969, P62829, P18077, P36578 | RPS6, RPS12, RPL9, RPL23, RPL35A, RPL4 | More | | Sulindac | hsa03013 | RNA transport | 1.12E-03 | 17 | P62826, O14980, P52298, Q09161, O14893, P61326, Q9UBU9, Q7Z3B4, P35658, P63279, P68104, Q14152, O75822, Q14240, Q9Y6A5, Q14232, P51114 | RAN, XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, NXF1, NUP54, NUP214, UBE2I, EEF1A1, EIF3A, EIF3J, EIF4A2, TACC3, EIF2B1, FXR1 | More | | Sulindac | hsa03020 | RNA polymerase | 6.08E-05 | 4 | P30876, P24928, P62487, Q9Y535 | POLR2B, POLR2A, POLR2G, POLR3H | More | | Sulindac | hsa03040 | Spliceosome | 3.37E-05 | 11 | Q14562, O43143, O60508, Q99633, P26368, Q13595, Q01130, Q13243, Q9UMS4, P11142, O43447 | DHX8, DHX15, CDC40, PRPF18, U2AF2, TRA2A, SFRS2, SFRS5, PRPF19, HSPA8, PPIH | More | | Sulindac | hsa03450 | Non-homologous end-joining | 4.96E-02 | 1 | Q9NP87 | POLM | More | | Sulindac | hsa04015 | Rap1 signaling pathway | 1.58E-02 | 6 | P20827, P49767, P63261, P25116, P0DP23, P17252 | EFNA1, VEGFC, ACTG1, F2R, CALM1, PRKCA | More | | Sulindac | hsa04020 | Calcium signaling pathway | 1.93E-04 | 10 | Q08828, Q16566, P17252, O15399, P25116, P0DP23, P05141, P51828, P23634, P49767 | ADCY1, CAMK4, PRKCA, GRIN2D, F2R, CALM1, SLC25A5, ADCY7, ATP2B4, VEGFC | More | | Sulindac | hsa04022 | cGMP-PKG signaling pathway | 4.38E-03 | 6 | P18848, P31751, Q08828, P51828, P05141, P0DP23 | ATF4, AKT2, ADCY1, ADCY7, SLC25A5, CALM1 | More | | Sulindac | hsa04024 | cAMP signaling pathway | 2.95E-03 | 8 | Q08828, P51828, P31751, P0DP23, P23634, Q16566, O15399, P25116 | ADCY1, ADCY7, AKT2, CALM1, ATP2B4, CAMK4, GRIN2D, F2R | More | | Sulindac | hsa04060 | Cytokine-cytokine receptor interaction | 8.61E-03 | 9 | P14784, P27930, P14778, Q13651, Q9HBE5, P25024, Q9UBD3, P47992, Q93038 | IL2RB, IL1R2, IL1R1, IL10RA, IL21R, CXCR1, XCL2, XCL1, TNFRSF25 | More | | Sulindac | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 2.06E-03 | 6 | Q8NHW4, P25024, P47992, Q9UBD3, Q13651, P14784 | CCL4L2, CXCR1, XCL1, XCL2, IL10RA, IL2RB | More | | Sulindac | hsa04062 | Chemokine signaling pathway | 4.68E-03 | 8 | P25024, P47992, Q9UBD3, P07948, P42338, P63218, P50151, P49407 | CXCR1, XCL1, XCL2, LYN, PIK3CB, GNG5, GNG10, ARRB1 | More | | Sulindac | hsa04064 | NF-kappa B signaling pathway | 6.91E-06 | 15 | P10415, O00463, P14778, P01584, Q04759, Q9UDY8, Q13077, Q16548, Q8WV28, Q13315, P63279, P24522, Q8NHW4, P09341, Q9NQC7 | BCL2, TRAF5, IL1R1, IL1B, PRKCQ, MALT1, TRAF1, BCL2A1, BLNK, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, CYLD | More | | Sulindac | hsa04070 | Phosphatidylinositol signaling system | 9.86E-03 | 4 | P0DP23, O14986, Q16760, P48426 | CALM1, PIP5K1B, DGKD, PIP4K2A | More | | Sulindac | hsa04071 | Sphingolipid signaling pathway | 1.88E-05 | 8 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Sulindac | hsa04072 | Phospholipase D signaling pathway | 2.40E-03 | 6 | P31751, O14986, Q15438, Q08828, P51828, Q16760 | AKT2, PIP5K1B, PSCD1, ADCY1, ADCY7, DGKD | More | | Sulindac | hsa04080 | Neuroactive ligand-receptor interaction | 1.00E-02 | 7 | P08311, Q15722, P21453, Q9H228, O00398, P21730, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, ADRB2 | More | | Sulindac | hsa04110 | Cell cycle | 6.63E-04 | 6 | P06493, O60566, P30304, P33981, P42773, P01106 | CDK1, BUB1B, CDC25A, TTK, CDKN2C, MYC | More | | Sulindac | hsa04114 | Oocyte meiosis | 1.35E-02 | 5 | P0DP23, Q08828, P51828, Q13362, Q14738 | CALM1, ADCY1, ADCY7, PPP2R5C, PPP2R5D | More | | Sulindac | hsa04140 | Autophagy - animal | 1.92E-03 | 9 | P31751, Q7L523, O75460, P22694, Q14643, P10415, Q04759, Q96GC9, Q8TEV9 | AKT2, RRAGA, ERN1, PRKACB, ITPR1, BCL2, PRKCQ, TMEM49, SMCR8 | More | | Sulindac | hsa04141 | Protein processing in endoplasmic reticulum | 2.01E-03 | 7 | P18848, P30101, O60337, P60604, P11142, P07900, P08238 | ATF4, PDIA3, MARH6, UBE2G2, HSPA8, HSP90AA1, HSP90AB1 | More | | Sulindac | hsa04145 | Phagosome | 1.48E-04 | 11 | O75015, P63261, Q15080, Q13509, P68371, Q13488, P05164, O60603, P35443, P27824, P13765 | FCGR3B, ACTG1, NCF4, TUBB3, TUBB2C, TCIRG1, MPO, TLR2, THBS4, CANX, HLA-DOB | More | | Sulindac | hsa04210 | Apoptosis | 3.44E-02 | 7 | Q13315, P10415, O76075, P24522, Q16548, P43234, Q14643 | ATM, BCL2, DFFB, GADD45A, BCL2A1, CTSO, ITPR1 | More | | Sulindac | hsa04211 | Longevity regulating pathway | 1.88E-02 | 4 | P31751, Q08828, P51828, P18848 | AKT2, ADCY1, ADCY7, ATF4 | More | | Sulindac | hsa04213 | Longevity regulating pathway - multiple species | 4.54E-02 | 3 | P31751, Q08828, P51828 | AKT2, ADCY1, ADCY7 | More | | Sulindac | hsa04217 | Necroptosis | 4.42E-04 | 6 | P07900, P15104, P05141, P01584, P0C0S5, Q13557 | HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, CAMK2D | More | | Sulindac | hsa04261 | Adrenergic signaling in cardiomyocytes | 4.98E-04 | 7 | Q08828, P51828, P31751, P18848, Q13362, Q14738, P0DP23 | ADCY1, ADCY7, AKT2, ATF4, PPP2R5C, PPP2R5D, CALM1 | More | | Sulindac | hsa04340 | Hedgehog signaling pathway | 3.09E-02 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | | Sulindac | hsa04350 | TGF-beta signaling pathway | 4.88E-02 | 1 | P37173 | TGFBR2 | More | | Sulindac | hsa04371 | Apelin signaling pathway | 3.94E-02 | 4 | P31751, Q08828, P51828, P0DP23 | AKT2, ADCY1, ADCY7, CALM1 | More | | Sulindac | hsa04380 | Osteoclast differentiation | 5.27E-04 | 10 | Q9NQC7, Q9UQC2, Q16539, P23458, P31751, P01584, P14778, O75015, P01375, Q8N149 | CYLD, GAB2, MAPK14, JAK1, AKT2, IL1B, IL1R1, FCGR3B, TNF, LILRA2 | More | | Sulindac | hsa04390 | Hippo signaling pathway | 2.11E-03 | 6 | P63261, Q13485, O15105, Q9UJU2, O43623, Q13489 | ACTG1, SMAD4, SMAD7, LEF1, SNAI2, BIRC3 | More | | Sulindac | hsa04510 | Focal adhesion | 3.21E-02 | 6 | Q15942, P17252, Q13489, P10415, P49767, P63261 | ZYX, PRKCA, BIRC3, BCL2, VEGFC, ACTG1 | More | | Sulindac | hsa04520 | Adherens junction | 3.36E-02 | 4 | Q13485, Q9UJU2, O43623, P63261 | SMAD4, LEF1, SNAI2, ACTG1 | More | | Sulindac | hsa04530 | Tight junction | 4.35E-02 | 2 | P63261, Q92974 | ACTG1, ARHGEF2 | More | | Sulindac | hsa04540 | Gap junction | 4.76E-02 | 3 | P17252, Q13509, P68371 | PRKCA, TUBB3, TUBB2C | More | | Sulindac | hsa04610 | Complement and coagulation cascades | 3.19E-02 | 1 | P0C0L4 | C4A | More | | Sulindac | hsa04612 | Antigen processing and presentation | 4.48E-02 | 5 | P13765, P26715, P26717, Q13241, P01732 | HLA-DOB, KLRC1, KLRC2, KLRD1, CD8A | More | | Sulindac | hsa04613 | Neutrophil extracellular trap formation | 1.70E-03 | 14 | P17252, O60603, P05164, P08246, Q9UM07, Q6FI13, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | PRKCA, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Sulindac | hsa04614 | Renin-angiotensin system | 1.52E-02 | 1 | P50052 | AGTR2 | More | | Sulindac | hsa04620 | Toll-like receptor signaling pathway | 2.54E-03 | 3 | P01584, P31751, Q8NHW4 | IL1B, AKT2, CCL4L2 | More | | Sulindac | hsa04623 | Cytosolic DNA-sensing pathway | 2.21E-04 | 3 | P01584, Q9Y535, Q8NHW4 | IL1B, POLR3H, CCL4L2 | More | | Sulindac | hsa04625 | C-type lectin receptor signaling pathway | 1.14E-03 | 8 | Q9ULY5, P01584, Q9NQC7, P20749, P01375, P31751, P0DP23, Q16539 | CLEC4E, IL1B, CYLD, BCL3, TNF, AKT2, CALM1, MAPK14 | More | | Sulindac | hsa04630 | JAK-STAT signaling pathway | 4.54E-02 | 3 | P31751, P23458, Q13651 | AKT2, JAK1, IL10RA | More | | Sulindac | hsa04640 | Hematopoietic cell lineage | 2.46E-03 | 8 | P14778, P27930, P25063, P07766, P01732, P01730, P06127, P09564 | IL1R1, IL1R2, CD24, CD3E, CD8A, CD4, CD5, CD7 | More | | Sulindac | hsa04650 | Natural killer cell mediated cytotoxicity | 2.96E-02 | 6 | O60880, P20963, Q13241, P26718, P26717, P26715 | SH2D1A, CD247, KLRD1, KLRK1, KLRC2, KLRC1 | More | | Sulindac | hsa04657 | IL-17 signaling pathway | 1.62E-04 | 8 | P07900, O00463, Q16539, P49841, P09341, P14780, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, CXCL1, MMP9, TNF, IL1B | More | | Sulindac | hsa04658 | Th1 and Th2 cell differentiation | 1.31E-06 | 11 | Q04759, P07766, P20963, P09693, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Sulindac | hsa04659 | Th17 cell differentiation | 2.42E-05 | 11 | Q04759, P06239, P14784, P13765, P14778, Q9HBE5, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, LCK, IL2RB, HLA-DOB, IL1R1, IL21R, TBX21, GATA3, CD3E, CD3G, CD247 | More | | Sulindac | hsa04660 | T cell receptor signaling pathway | 1.29E-04 | 11 | Q9UDY8, Q04759, P42338, P10747, Q08881, P07766, P20963, P09693, P01732, Q13191, P06239 | MALT1, PRKCQ, PIK3CB, CD28, ITK, CD3E, CD247, CD3G, CD8A, CBLB, LCK | More | | Sulindac | hsa04662 | B cell receptor signaling pathway | 4.02E-03 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Sulindac | hsa04664 | Fc epsilon RI signaling pathway | 3.98E-02 | 3 | P01375, Q16539, Q9UQC2 | TNF, MAPK14, GAB2 | More | | Sulindac | hsa04668 | TNF signaling pathway | 2.21E-02 | 5 | P01375, O00463, Q16539, P20749, P14780 | TNF, TRAF5, MAPK14, BCL3, MMP9 | More | | Sulindac | hsa04710 | Circadian rhythm | 1.67E-02 | 2 | Q16526, Q9Y478 | CRY1, PRKAB1 | More | | Sulindac | hsa04713 | Circadian entrainment | 4.54E-02 | 3 | P0DP23, Q08828, P51828 | CALM1, ADCY1, ADCY7 | More | | Sulindac | hsa04720 | Long-term potentiation | 4.13E-04 | 6 | P17252, Q16566, P0DP23, P18848, O15399, Q08828 | PRKCA, CAMK4, CALM1, ATF4, GRIN2D, ADCY1 | More | | Sulindac | hsa04723 | Retrograde endocannabinoid signaling | 1.75E-02 | 5 | Q14643, P17252, P22694, Q16539, Q16718 | ITPR1, PRKCA, PRKACB, MAPK14, NDUFA5 | More | | Sulindac | hsa04725 | Cholinergic synapse | 1.39E-02 | 4 | Q08828, P51828, P18848, P31751 | ADCY1, ADCY7, ATF4, AKT2 | More | | Sulindac | hsa04728 | Dopaminergic synapse | 7.83E-03 | 5 | P31751, P18848, Q13362, Q14738, P0DP23 | AKT2, ATF4, PPP2R5C, PPP2R5D, CALM1 | More | | Sulindac | hsa04730 | Long-term depression | 1.35E-02 | 2 | Q14344, P07948 | GNA13, LYN | More | | Sulindac | hsa04750 | Inflammatory mediator regulation of TRP channels | 4.76E-04 | 8 | P14778, P01584, Q08828, P51828, P42338, P24723, Q04759, P0DP23 | IL1R1, IL1B, ADCY1, ADCY7, PIK3CB, PRKCH, PRKCQ, CALM1 | More | | Sulindac | hsa04911 | Insulin secretion | 2.40E-02 | 3 | Q08828, P51828, P18848 | ADCY1, ADCY7, ATF4 | More | | Sulindac | hsa04912 | GnRH signaling pathway | 2.67E-04 | 9 | P17252, Q08828, P51828, P18848, Q16539, Q9Y6R4, Q14643, P0DP23, P22694 | PRKCA, ADCY1, ADCY7, ATF4, MAPK14, MAP3K4, ITPR1, CALM1, PRKACB | More | | Sulindac | hsa04915 | Estrogen signaling pathway | 2.13E-02 | 5 | P18848, Q08828, P51828, P31751, P0DP23 | ATF4, ADCY1, ADCY7, AKT2, CALM1 | More | | Sulindac | hsa04916 | Melanogenesis | 1.98E-03 | 5 | P0DP23, Q9UJU2, Q08828, P51828, P17252 | CALM1, LEF1, ADCY1, ADCY7, PRKCA | More | | Sulindac | hsa04920 | Adipocytokine signaling pathway | 4.31E-02 | 2 | Q9Y478, Q96RR4 | PRKAB1, CAMKK2 | More | | Sulindac | hsa04921 | Oxytocin signaling pathway | 4.19E-02 | 4 | P0DP23, P17252, Q16566, P63261 | CALM1, PRKCA, CAMK4, ACTG1 | More | | Sulindac | hsa04922 | Glucagon signaling pathway | 4.23E-02 | 4 | P22694, P06737, Q12778, Q14643 | PRKACB, PYGL, FOXO1, ITPR1 | More | | Sulindac | hsa04923 | Regulation of lipolysis in adipocytes | 5.15E-03 | 3 | Q08828, P51828, P31751 | ADCY1, ADCY7, AKT2 | More | | Sulindac | hsa04924 | Renin secretion | 1.04E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Sulindac | hsa04925 | Aldosterone synthesis and secretion | 1.84E-04 | 7 | P18848, Q08828, P51828, P0DP23, P17252, Q16566, P23634 | ATF4, ADCY1, ADCY7, CALM1, PRKCA, CAMK4, ATP2B4 | More | | Sulindac | hsa04926 | Relaxin signaling pathway | 2.46E-02 | 4 | P31751, P18848, Q08828, P51828 | AKT2, ATF4, ADCY1, ADCY7 | More | | Sulindac | hsa04927 | Cortisol synthesis and secretion | 1.59E-02 | 3 | P18848, Q08828, P51828 | ATF4, ADCY1, ADCY7 | More | | Sulindac | hsa04928 | Parathyroid hormone synthesis, secretion and action | 4.10E-03 | 5 | Q14643, P22694, P23771, P17252, P10415 | ITPR1, PRKACB, GATA3, PRKCA, BCL2 | More | | Sulindac | hsa04932 | Non-alcoholic fatty liver disease | 2.99E-04 | 7 | P31751, P18848, O75460, P01584, P13073, O15239, O95298 | AKT2, ATF4, ERN1, IL1B, COX4I1, NDUFA1, NDUFC2 | More | | Sulindac | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.36E-02 | 4 | Q13485, P10415, P49767, P17252 | SMAD4, BCL2, VEGFC, PRKCA | More | | Sulindac | hsa04934 | Cushing syndrome | 4.54E-02 | 3 | P18848, Q08828, P51828 | ATF4, ADCY1, ADCY7 | More | | Sulindac | hsa04935 | Growth hormone synthesis, secretion and action | 1.88E-02 | 4 | Q08828, P51828, P18848, P31751 | ADCY1, ADCY7, ATF4, AKT2 | More | | Sulindac | hsa04950 | Maturity onset diabetes of the young | 2.03E-02 | 1 | P35557 | GCK | More | | Sulindac | hsa04970 | Salivary secretion | 1.38E-03 | 5 | Q08828, P51828, P23634, P17252, P0DP23 | ADCY1, ADCY7, ATP2B4, PRKCA, CALM1 | More | | Sulindac | hsa04971 | Gastric acid secretion | 4.13E-04 | 6 | Q08828, P51828, P17252, P15311, P63261, P0DP23 | ADCY1, ADCY7, PRKCA, VIL2, ACTG1, CALM1 | More | | Sulindac | hsa04976 | Bile secretion | 1.59E-02 | 3 | Q08828, P51828, Q14032 | ADCY1, ADCY7, BAAT | More | | Sulindac | hsa04978 | Mineral absorption | 3.94E-02 | 2 | P23634, Q9BXS9 | ATP2B4, SLC26A6 | More | | Sulindac | hsa05010 | Alzheimer disease | 4.94E-03 | 9 | O95298, Q00535, O75460, P0DP23, P01584, P18848, P31751, P05141, P28070 | NDUFC2, CDK5, ERN1, CALM1, IL1B, ATF4, AKT2, SLC25A5, PSMB4 | More | | Sulindac | hsa05012 | Parkinson disease | 1.59E-03 | 9 | O15239, P13073, P05141, P21796, P60604, P18848, Q13557, Q71U36, Q13509 | NDUFA1, COX4I1, SLC25A5, VDAC1, UBE2G2, ATF4, CAMK2D, TUBA1A, TUBB3 | More | | Sulindac | hsa05014 | Amyotrophic lateral sclerosis | 4.31E-02 | 7 | O15399, P10415, Q13509, P68371, Q53GS7, P63261, Q9GZY0 | GRIN2D, BCL2, TUBB3, TUBB2C, GLE1, ACTG1, NXF2; NXF2B | More | | Sulindac | hsa05016 | Huntington disease | 2.14E-03 | 9 | O15239, O95298, P13073, P24928, P30876, P62487, P05141, O75460, P28070 | NDUFA1, NDUFC2, COX4I1, POLR2A, POLR2B, POLR2G, SLC25A5, ERN1, PSMB4 | More | | Sulindac | hsa05017 | Spinocerebellar ataxia | 3.94E-02 | 4 | O75460, P31751, P28070, P05141 | ERN1, AKT2, PSMB4, SLC25A5 | More | | Sulindac | hsa05020 | Prion disease | 3.30E-04 | 10 | P13591, P01584, P11142, O15239, P13073, P18848, P05141, P21796, Q71U36, Q13509 | NCAM1, IL1B, HSPA8, NDUFA1, COX4I1, ATF4, SLC25A5, VDAC1, TUBA1A, TUBB3 | More | | Sulindac | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.89E-04 | 17 | Q71U36, Q13509, O15239, O95298, P13073, Q8TEV9, P21796, O75460, P18848, P05141, Q00535, P04628, P01584, P0DP23, Q13557, P28070, P60604 | TUBA1A, TUBB3, NDUFA1, NDUFC2, COX4I1, SMCR8, VDAC1, ERN1, ATF4, SLC25A5, CDK5, WNT1, IL1B, CALM1, CAMK2D, PSMB4, UBE2G2 | More | | Sulindac | hsa05031 | Amphetamine addiction | 1.49E-02 | 4 | O15399, P0DP23, Q16566, P17252 | GRIN2D, CALM1, CAMK4, PRKCA | More | | Sulindac | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.45E-02 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | | Sulindac | hsa05132 | Salmonella infection | 4.98E-02 | 6 | Q9UJU2, P63261, Q13489, P10415, Q13509, P68371 | LEF1, ACTG1, BIRC3, BCL2, TUBB3, TUBB2C | More | | Sulindac | hsa05133 | Pertussis | 1.60E-03 | 5 | P0DP23, P10145, P23528, P09871, P0C0L4 | CALM1, IL8, CFL1, C1S, C4A | More | | Sulindac | hsa05134 | Legionellosis | 1.28E-02 | 3 | P01584, P68104, P11142 | IL1B, EEF1A1, HSPA8 | More | | Sulindac | hsa05140 | Leishmaniasis | 2.69E-02 | 5 | O75015, P13765, O60603, P49006, Q16539 | FCGR3B, HLA-DOB, TLR2, MARCKSL1, MAPK14 | More | | Sulindac | hsa05146 | Amoebiasis | 4.73E-04 | 8 | P09341, P14778, P27930, O60603, P42338, P05089, P12814, P08311 | CXCL1, IL1R1, IL1R2, TLR2, PIK3CB, ARG1, ACTN1, CTSG | More | | Sulindac | hsa05152 | Tuberculosis | 1.26E-02 | 8 | Q13488, O75015, P48382, O60603, P10415, P13765, Q9UDY8, Q16539 | TCIRG1, FCGR3B, RFX5, TLR2, BCL2, HLA-DOB, MALT1, MAPK14 | More | | Sulindac | hsa05162 | Measles | 4.02E-02 | 3 | P11142, P01584, Q9NP90 | HSPA8, IL1B, RAB9B | More | | Sulindac | hsa05163 | Human cytomegalovirus infection | 4.02E-06 | 17 | P31751, P01375, Q14643, P0DP23, Q8NHW4, Q08828, P51828, P23458, P49841, P14778, P01584, Q13651, P25025, Q16539, P18848, P04637, O00463 | AKT2, TNF, ITPR1, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, IL10RA, CXCR2, MAPK14, ATF4, TP53, TRAF5 | More | | Sulindac | hsa05164 | Influenza A | 4.49E-02 | 5 | P31751, P01584, P23458, P05141, Q9UBU9 | AKT2, IL1B, JAK1, SLC25A5, NXF1 | More | | Sulindac | hsa05166 | Human T-cell leukemia virus 1 infection | 3.90E-02 | 7 | P23458, P05141, P62826, Q08828, P51828, P18848, P31751 | JAK1, SLC25A5, RAN, ADCY1, ADCY7, ATF4, AKT2 | More | | Sulindac | hsa05168 | Herpes simplex virus 1 infection | 1.94E-02 | 9 | Q9UKJ0, P01568, Q9GZY0, Q01130, Q13489, Q13398, Q03923, Q9UDV6, P10415 | PILRB, IFNA21, NXF2; NXF2B, SFRS2, BIRC3, ZNF211, ZNF85, ZNF212, BCL2 | More | | Sulindac | hsa05171 | Coronavirus disease - COVID-19 | 9.72E-03 | 7 | P01584, P62753, P25398, P36578, P32969, P18077, P62829 | IL1B, RPS6, RPS12, RPL4, RPL9, RPL35A, RPL23 | More | | Sulindac | hsa05200 | Pathways in cancer | 1.51E-02 | 12 | Q9UJU2, P17252, P43246, Q13485, P14923, P10415, Q13489, P49767, P25116, P78417, P0DP23, P01568 | LEF1, PRKCA, MSH2, SMAD4, JUP, BCL2, BIRC3, VEGFC, F2R, GSTO1, CALM1, IFNA21 | More | | Sulindac | hsa05202 | Transcriptional misregulation in cancer | 2.67E-04 | 14 | Q12778, Q15532, Q13315, P41732, P14780, P27930, Q16548, Q13489, O15550, P35226, P05164, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, TSPAN7, MMP9, IL1R2, BCL2A1, BIRC3, UTX, BMI1, MPO, ELA2, BCL11B, GADD45A | More | | Sulindac | hsa05203 | Viral carcinogenesis | 4.62E-02 | 3 | Q12933, P42229, Q15283 | TRAF2, STAT5A, RASA2 | More | | Sulindac | hsa05204 | Chemical carcinogenesis | 5.46E-03 | 2 | Q16772, P09211 | GSTA3, GSTP1 | More | | Sulindac | hsa05212 | Pancreatic cancer | 4.00E-03 | 4 | P31751, Q15311, P23458, P37173 | AKT2, RALBP1, JAK1, TGFBR2 | More | | Sulindac | hsa05214 | Glioma | 3.55E-02 | 3 | P0DP23, Q16566, P17252 | CALM1, CAMK4, PRKCA | More | | Sulindac | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | | Sulindac | hsa05224 | Breast cancer | 4.75E-02 | 4 | P49841, Q92837, P04637, P24522 | GSK3B, FRAT1, TP53, GADD45A | More | | Sulindac | hsa05231 | Choline metabolism in cancer | 3.38E-02 | 3 | P31751, Q16760, O14986 | AKT2, DGKD, PIP5K1B | More | | Sulindac | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.70E-04 | 11 | P42338, O95267, P07766, P20963, P09693, P06239, O60603, P10747, Q04759, Q16539, P01730 | PIK3CB, RASGRP1, CD3E, CD247, CD3G, LCK, TLR2, CD28, PRKCQ, MAPK14, CD4 | More | | Sulindac | hsa05321 | Inflammatory bowel disease | 1.66E-04 | 5 | O60603, P13765, Q14765, Q9UL17, P23771 | TLR2, HLA-DOB, STAT4, TBX21, GATA3 | More | | Sulindac | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | | Sulindac | hsa05332 | Graft-versus-host disease | 1.16E-04 | 4 | P13765, P10747, P26715, Q13241 | HLA-DOB, CD28, KLRC1, KLRD1 | More | | Sulindac | hsa05415 | Diabetic cardiomyopathy | 2.87E-02 | 4 | P05141, O15239, P13073, Q13557 | SLC25A5, NDUFA1, COX4I1, CAMK2D | More | | Sulindac | hsa05418 | Fluid shear stress and atherosclerosis | 9.76E-06 | 13 | Q16539, Q14145, P78417, P10599, P14780, P01375, P63261, P04637, P10415, P14778, P27930, P0DP23, Q92974 | MAPK14, KEAP1, GSTO1, TXN, MMP9, TNF, ACTG1, TP53, BCL2, IL1R1, IL1R2, CALM1, ARHGEF2 | More | | |